BVS (STOCKS)
Bioventus Inc. Class A Common Stock
$13.890000
-0.025000 (-0.18%)
Prev close: $13.915000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Robert E. Claypoole
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,207.49M
- Employees
- 950
- P/E (TTM)
- 17.95
- P/B (TTM)
- 4.16
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $581.85M |
| Benefits Costs and Expenses | $543.21M |
| Cost Of Revenue | $182.40M |
| Costs And Expenses | $543.21M |
| Gross Profit | $399.45M |
| Nonoperating Income/Loss | -$19.64M |
| Operating Expenses | $341.17M |
| Selling, General, and Administrative Expenses | $322.48M |
| Depreciation and Amortization | $4.84M |
| Research and Development | $11.57M |
| Other Operating Expenses | $2.27M |
| Operating Income/Loss | $58.28M |
| Income/Loss From Continuing Operations After Tax | $61.48M |
| Income/Loss From Continuing Operations Before Tax | $38.64M |
| Income Tax Expense/Benefit | -$22.84M |
| Net Income/Loss | $61.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $7.01M |
| Net Income/Loss Attributable To Parent | $54.46M |
| Net Income/Loss Available To Common Stockholders, Basic | $54.46M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.81 |
| Diluted Earnings Per Share | $0.77 |
| Basic Average Shares | 202,229,650 |
| Diluted Average Shares | 209,807,342 |
| Assets | $673.35M |
| Current Assets | $257.53M |
| Inventory | $79.81M |
| Other Current Assets | $177.72M |
| Noncurrent Assets | $415.82M |
| Intangible Assets | $351.05M |
| Other Non-current Assets | $64.77M |
| Liabilities | $395.93M |
| Current Liabilities | $152.45M |
| Accounts Payable | $20.20M |
| Other Current Liabilities | $132.26M |
| Noncurrent Liabilities | $243.48M |
| Equity | $277.41M |
| Equity Attributable To Noncontrolling Interest | $49.11M |
| Equity Attributable To Parent | $228.31M |
| Liabilities And Equity | $673.35M |
| Net Cash Flow From Operating Activities | $96.87M |
| Net Cash Flow From Operating Activities, Continuing | $96.87M |
| Net Cash Flow From Investing Activities | -$4.09M |
| Net Cash Flow From Investing Activities, Continuing | -$4.09M |
| Net Cash Flow From Financing Activities | -$95.00M |
| Net Cash Flow From Financing Activities, Continuing | -$95.00M |
| Exchange Gains/Losses | -$1.24M |
| Net Cash Flow | -$3.45M |
| Net Cash Flow, Continuing | -$2.21M |
| Comprehensive Income/Loss | $60.79M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $6.88M |
| Comprehensive Income/Loss Attributable To Parent | $53.91M |
| Other Comprehensive Income/Loss | $304.00K |